User profiles for J. A. Wedzicha

Jadwiga Wedzicha

National Heart and Lung Institute, Imperial College London
Verified email at imperial.ac.uk
Cited by 77714

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019

…, R Stockley, J Vestbo, JA Wedzicha… - European …, 2019 - Eur Respiratory Soc
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic
and biological information in order to optimise the therapeutic benefit relative to the …

[HTML][HTML] COPD exacerbations: defining their cause and prevention

JA Wedzicha, TAR Seemungal - The lancet, 2007 - thelancet.com
Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening
of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are …

Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic …

JV Lightowler, JA Wedzicha, MW Elliott, FSF Ram - Bmj, 2003 - bmj.com
Objectives: To determine the effectiveness of non-invasive positive pressure ventilation (NPPV)
in the management of respiratory failure secondary to acute exacerbation of chronic …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

…, R Stockley, J Vestbo, JA Wedzicha… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

…, R Garrod, R Garnham, PW Jones, JA Wedzicha - Thorax, 1999 - thorax.bmj.com
BACKGROUND Methods of classifying chronic obstructive pulmonary disease (COPD)
depend largely upon spirometric measurements but disability is only weakly related to …

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

…, TAR Seemungal, A Bhowmik, JA Wedzicha - Thorax, 2002 - thorax.bmj.com
Background: Chronic obstructive pulmonary disease (COPD) is characterised by both an
accelerated decline in lung function and periods of acute deterioration in symptoms termed …

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease

…, JC Bestall, DJ Jeffries, JA Wedzicha - American journal of …, 1998 - atsjournals.org
… Meecham Jones, DJ, EA Paul, PW Jones, and JA WedzichaNasal pressure support … JA
Wedzicha, Academic Department of Respiratory Medicine, The London Chest Hospital, …

Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease

…, A Bhowmik, DJ Jeffries, JA Wedzicha - American journal of …, 2000 - atsjournals.org
Although exacerbations of chronic obstructive pulmonary disease (COPD) are associated
with symptomatic and physiological deterioration, little is known of the time course and …

Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease

…, EA Paul, MW Elliott, RC Godfrey, JA Wedzicha… - The Lancet, 1993 - Elsevier
Acute exacerbations of chronic obstructive airways disease (COAD) are a common cause of
admission to hospital, and have a high mortality. Nasal intermittent positive pressure …

Outcomes for COPD pharmacological trials: from lung function to biomarkers

…, R Stockley, SD Sullivan, JA Wedzicha… - European respiratory …, 2008 - Eur Respiratory Soc
The American Thoracic Society/European Respiratory Society jointly created a Task Force
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …